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Summary
Objective: Apoptosis appears to be a significant mechanism of chondrocyte death in osteoarthritis (OA). There is increasing evidence that
nitric oxide (NO) may be the inducing signal for apoptosis, but no study has definitively shown an association between the two in vivo. In this
study, sections of osteoarthritic cartilage were double stained for the presence of apoptosis and NO to test the hypothesis that NO is the
inducer of apoptosis in arthritis.
Design: Sections of osteoarthritic cartilage obtained during total knee arthroplasty were stained for apoptosis with terminal transferase-
mediated dUTP nick end labeling (TUNEL). The sections were then stained for nitrotyrosine (a marker of NO production) by immunohisto-
chemistry. The prevalence of NO in cells positive for apoptosis and in cells negative for apoptosis was determined by fluorescent microscopy.
Results: The prevalence of NO in apoptotic cells was no different than in non-apoptotic cells, suggesting NO is not the initiating signal for
apoptosis in vivo.
Conclusions: The precipitating cause for apoptosis in arthritic chondrocytes has not yet been determined. The data from this study fail to
support NO as the direct initiating signal. NO synthase inhibitors may still be useful in the treatment of OA by blocking the catabolic activities
of NO. © 2002 OsteoArthritis Research Society International
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Apoptosis, sometimes referred to as programmed cell
death, has been identified as a mechanism of chondrocyte
death in human osteoarthritis (OA). There is increasing
evidence that nitric oxide (NO) may be the inducing signal
for apoptosis in articular cartilage. NO is a cellular signaling
molecule which has been previously shown to inhibit pro-
teoglycan synthesis1 and enhance matrix metalloprotease
activity2. In vitro, apoptosis can be induced by exposure
to NO in the presence of oxygen radical scavengers3.
Apoptotic chondrocytes and NO have been separately
identified in articular cartilage of patients with OA and
rheumatoid arthritis (RA), and both apoptosis and NO were
more prevalent in more severely involved sections4–8. In an
animal model of OA, the addition of NO synthase inhibitors
led to a reduction in osteophyte formation and gross
cartilage degeneration, and also resulted in a decreased
prevalence of chondrocyte apoptosis9,10 While the data
suggests that NO may be the initiating signal for apoptosis
in vivo, it is also possible that the beneficial effects of NO
synthase inhibitors arise from inhibition of the catabolic
activities of NO, and that apoptosis is only a secondary
result of end-stage matrix degradation.–
207No previous study has measured apoptosis and NO
production in the same tissue sections or in the same
cells. In this study, sections of osteoarthritic cartilage were
double stained for apoptosis and NO to test the hypothesis
that NO is the inducer of apoptosis in arthritis. If the
hypothesis is correct, the prevalence of NO in apoptotic
chondrocytes will be higher than in non-apoptotic cells.Methods
Osteoarthritic cartilage was obtained from five patients
undergoing total knee arthroplasty. Three to five osteo-
chondral specimens of cartilage were harvested from the
femoral or patellar articular surfaces of each individual
and were immediately fixed in 10% neutral buffered
formalin for 24 h, decalcified in EDTA for 5 days, and then
embedded in paraffin. Seven m serial sections were
used for the histologic grading of OA and for fluorescent
histochemistry.Received 9 May 2001; revision requested 24 July 2001; revision
received 7 September 2001; accepted 9 October 2001.
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Sections from each sample were deparaffinized and
rehydrated, and then stained with safranin-O and fast
green. The grade of OA for each specimen was determined
using the system of Mankin et al.11. This system evaluates
structure, cellularity, safranin-O staining, and integrity of the
tidemark of articular cartilage. Perfectly normal cartilage
scores zero, while the most severe arthritis scores14.
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A second tissue section from each sample immediately
adjacent to the first section was prepared for further stain-
ing as follows. Tissue samples were deparaffinized and
rehydrated, and then permeabilized by a 2 min dip in 0.1%
Triton X-100 in 0.1% citrate. Sections were then incubated
with 0.5 mg/ml sheep testicular hyaluronidase (Sigma,
St Louis, Missouri) at 37°C for 30 min. Apoptosis was
detected using a terminal transferase-mediated dUTP nick
end labeling (TUNEL) assay (In Situ Cell Death Detection
Kit, Roche Molecular Biochemicals, Indianapolis, IN). The
TUNEL assay labels the characteristic DNA strand breaks
of apoptosis with fluorescent nucleotides. Because normal
cells have very few strand breaks, little or no fluorescent
label is incorporated in normal cells. Prior to testing the
specimens, the terminal transferase levels were titrated so
that no staining occurred in normal cartilage (specimens
with no macro or microscopic evidence of arthritis), in order
to minimize false positives. (If the enzyme level is not
carefully titrated, normal cells will be falsely labeled with
fluorescent nucleotides.) Nucleotides were labeled with
fluorescein, which fluoresces green. The negative con-
trol consisted of fluorescein labeled nucleotides without
terminal transferase.STAINING FOR NO
NO reacts with the tyrosine residues of intracellular
proteins to form nitrotyrosine12,13. Antibodies to nitro-
tyrosine can be used to mark sites of NO production14,15.
After staining for apoptosis, the same tissue sections
were blocked with 5% normal goat serum. The sections
were exposed to 5 g/ml rabbit antinitrotyrosine (Upstate
Biotechnology, Lake Placid, NY) at room temperature for
1 h. The sections were then counterstained with goat
antibodies to rabbit gamma globulin (Sigma, St Louis, MO).
These antirabbit gamma globulin antibodies were labeled
with rhodamine, which fluoresces red. Negative controls
were stained with only the antirabbit antibody.
The sections were then mounted in media contain-
ing 4′,6 diamidino-2-phenylindole (DAPI, Vector Labs,
Burlingame, CA), which labels all nuclei fluorescent blue.
Thus, all cells which have nuclei in the section were labeled
blue.ANALYSIS
One image from each arthritic cartilage section was
acquired into Adobe Photoshop (Adobe Systems, San
Jose, California) on a fluorescent microscope (Nikon
Eclipse E800, Japan) in blue, green, and red fields at 200×
magnification. Each field was approximately 0.5 mm2 in
area and was chosen in a nonrandom manner to include
a relatively high number of cells staining positive for
apoptosis. Only cells which clearly stained blue (DAPI)
were included in the analysis. Thus, any cells which did not
have a nucleus in the section were excluded. This resulted
in 100 to 200 cells being analysed per section. Custom
software determined the co-localization of red (NO) and
green (apoptosis) fluorescence.
The prevalence of NO in cells positive for apoptosis (red
and green cells) was compared with that in cells negative
for apoptosis (cells that are red but not green). Results are
reported as means±standard deviation. Comparisons weremade with the two-tailed Student’s t-test, with a P-value of
0.05 as significant.Results
A total of 19 specimens were analysed from five individ-
uals with OA. The histologic arthritis grade ranged from four
to 11. In the normal (non-arthritic) control cartilage, the
prevalence of apoptosis was less than 1%.
Figure 1 shows typical images for one of the arthritic
specimens when red, green, and blue fluorescence were
examined simultaneously. Examples of cells positive for
both NO and apoptosis, NO alone, and normal cells are
shown. The blue and green staining of DAPI and the
TUNEL assay cause the nuclei to fluoresce, while NO
staining occurs in the cytoplasm.
Another specimen is shown in Fig. 2, where red, green,
and blue fluorescence were photographed separately. In
Fig. 2(a), the image was acquired under blue (DAPI)
fluorescence and shows all of the cells with nuclei in
the section. In Fig. 2(b), green fluorescence is examined,
and only those nuclei positive for apoptosis by the
TUNEL assay are fluorescent. Figure 2(c) is taken under
rhodamine (red) fluorescence, and cells positive for nitro-
tyrosine are shown. Nitrotyrosine is present in the cyto-
plasm of affected cells, so the fluorescent pattern
surrounds the dark nucleus. Negative controls showed no
cellular staining.
Chondrocytes tended to stain for both apoptosis and NO
in small clusters of 2–4 cells. This has been observed also
in previous studies5. The prevalence of apoptosis in the
arthritic sections was 31±10% (range 16–63%). The preva-
lence of NO in the analysed cells was 47±20% (range
5–74%).
The prevalence of NO in apoptotic cells was 49±23%,
while 46±22% of non-apoptotic cells were positive for NO.
The difference between these means was not significant
(P=0.23).Discussion
Previous studies have linked NO and cell death in
arthritic cartilage, but it is not known if NO is the inducer of
chondrocyte apoptosis. Apoptotic cell death has been
identified in chondrocytes in vitro following exposure to NO
in the presence of oxygen radical scavengers3,16. This
NO-induced cell death can be blocked with selective
caspase inhibitors16. (Caspases are the enzymes which
carry out the tasks of apoptosis.) Sections of articular
cartilage from patients with RA and OA recovered during
hip and knee arthroplasty have stained positive for both NO
and apoptosis4–8. In humans, the enzyme NO synthase
has been observed (by immunohistochemistry) in apoptotic
chondrocytes8. These studies suggest a link between NO
and chondrocyte apoptosis in vivo.
Other evidence suggesting NO may be the signal for
apoptosis has come from animal models of OA. Anterior
cruciate ligament transection in dogs resulted in an
increased prevalence of apoptosis and NO in the affected
joint relative to the contralateral side15. The addition of
selective NO synthase inhibitors in this model reduced the
macroscopic progression of OA and reduced the preva-
lence of chondrocyte apoptosis9,17. The same NO syn-
thase inhibitors also lead to a decrease in production of
major catabolic factors, such as matrix metalloproteases
Osteoarthritis and Cartilage Vol. 10, No. 3 209Fig. 1. A section of osteoarthritic cartilage at 400× original magnification, viewed under red, green, and blue fluorescence simultaneously.
The cell marked 1 is apoptotic, with a green (TUNEL fluorescence) nucleus. This cell also has a red cytoplasm and so is positive for NO.
Another cell staining for NO, but negative for apoptosis (nucleus is blue (DAPI) only) is marked 2. Cell 3 is a normal cell, with a blue (DAPI)
nucleus and no significant cytoplasmic staining.and IL-1 beta18. Altogether, the data reveal an association
between NO and apoptosis in vivo, but it is unclear whether
cells are undergoing apoptosis in direct response to NO or
whether the observed cell death is an end result of the
known catabolic activities of NO and other inflammatory
mediators. Another study, using a rabbit model of OA,
found intraarticular hyaluronan injections decreased levels
of apoptosis but not NO19. That work suggests NO and
apoptosis may not be intimately associated.
In this study, the co-prevalence of apoptosis and NO was
examined by double staining microscopic specimens. If NO
was the initiating signal, then the prevalence of NO in
apoptotic cells should have been higher than in non-
apoptotic cells. However, there was no difference in the
prevalence of NO in these cells. Previous studies have
concluded that NO seems to be expressed in the same
regions of cartilage as apoptosis8,15,17, but no study has
quantified the prevalence of each in the same section or inthe same cells. The results of this study fail to support NO
as the direct signal for apoptosis in OA.
It is possible to speculate that the 46% of non-apoptotic
cells which were positive for NO had received the signal for
apoptosis but were too early in the process to be detected
by the TUNEL assay. If this hypothesis were true, then NO
could be the initiating signal. But apoptosis is a rapid
event20. In vitro, chondrocyte apoptosis follows exposure to
NO over a course of a few hours3. OA is a chronic disease,
and it is likely that the findings observed in this study had
been there for months or years. Thus, it is improbable that
the 46% of non-apoptotic cells which were positive for NO
were all about to undergo apoptosis.
While all evidence suggests apoptosis is a rapid event
once initiated, it is not known for how long nitrotyrosine
remains in the cytoplasm of cells following exposure to NO.
It is possible that the nitrotyrosine has been metabolized
and is gone from the cell, but then the cell undergoes
210 J. Greisberg et al.: The prevalence of nitric oxide in apoptotic chondrocytes of osteoarthritisapoptosis. In that hypothetical situation, cells would stain
positive for apoptosis but negative for NO even if NO was
the initiating signal. There were cells seen in this study
which stained for apoptosis but not for NO (data not
shown). However, if NO was the initiating signal, then the
prevalence of NO in apoptotic cells should still have been
higher than in non-apoptotic cells.
The significance of chondrocyte apoptosis in vivo is not
known, but it is reasonable to assume that for every cell
that is lost to apoptosis, there are fewer remaining cells to
maintain the matrix. Intervention to prevent it might be
useful as a treatment for (or as prevention of) OA. However,it is not known if apoptosis precedes the matrix degener-
ation or if it follows the arthritic process. The findings of this
study do not contradict previous work, which has shown an
association between apoptosis and NO. NO-induced acti-
vation of catabolic activities may ultimately lead to apopto-
sis in the same or neighboring cells. In this model, NO
leads to expression of catabolic signals which can affect
that cell or diffuse to surrounding chondrocytes and induce
apoptosis there.
Moreover, cell death by itself is probably not the central
event in arthritic degeneration of cartilage. Arthritic
chondrocytes show biochemical similarities to hypertrophic
cells of the growth plate, including production of type X
collagen and release of vesicles containing annexin V and
alkaline phosphatase21. In the normal physis, cells undergo
terminal differentiation and die, probably through an
apoptotic pathway. It has been proposed that the changes
seen in chondrocytes of arthritis represent a transition from
their normal stable phenotype to a terminal differentiation
similar to that seen in the physis21. As such, the cells
mineralize the matrix and then die. If this is true, then
intervention should focus on maintaining the stable pheno-
type (preventing terminal differentiation) rather than
blocking the cell death that follows terminal differentiation.
In conclusion, previous studies have shown that NO has
many catabolic effects on cartilage, and that NO synthase
inhibitors can delay the progression of arthritis in an animal
model. Some form of chondrocyte death is seen in human
arthritis, although it is not known if cell death precedes or
follows the matrix destruction. NO may not be the direct
signal for the cell death that occurs in human arthritis. NO
synthase inhibitors may still be useful in the treatment of
arthritis by blocking the catabolic activities of NO.Fig. 2. A section of arthritic cartilage at 200× original magnification
is shown here when red, green, and blue fluorescence are viewed
separately. (a) The section under blue fluorescence, where all
nuclei are stained by DAPI; (b) the same section under green
fluorescence, where only apoptotic nuclei stained by the TUNEL
technique are seen; (c) the same section, now under red fluor-
escence, and the cytoplasm of cells positive for NO are stained.
Note that in many cells it is possible to see the cytoplasmic pattern
surrounding a dark nucleus, but in other cells the nucleus is
artifactually obscured by the brightness of the cytoplasmic stain.References
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